Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Arnatar Therapeutics, Inc., explained in plain language.
This early-phase study tests a single injection of ART101 in 16 adults with high blood pressure. The goal is to see if it is safe and how it affects blood pressure over 24 weeks. Participants receive either 600 mg or 800 mg of the drug and are closely monitored.
Phase: PHASE1 • Sponsor: Arnatar Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC